2009•Central Plains Medical JournalRequires access

A controlled trial of extended release venlafaxine alone and combined with olanzapine in the treatment of major depression disorder

Qiaoping Chen, Qingmei Zheng, Zhiping Xu

Open publisher page 0 citations

Abstract

Objective To compare the therapeutic efficacy and safety of extended release venlafaxine combined with olanzapine in treatment of major depression disorder.Methods Seventy patients were randomly assigned to therapeutic group(n=35)and control group(n=35)for 8 weeks.Therapeutic group were given extended release venlafaxine combined with olanzapine,and control group were only given extended release venlafaxine.The clinical effect was regularly assessed with HAMD.Results The therapeutic efficacy in extended release venlafaxine combined with olanzapine group was significantly higher than that in control group.Conclusions Extended release venlafaxine combined with olanzapine has better therapeutic efficacy in treatment of major depression disorder. Key words: Extended release venlafaxine; Olanzapine; Major depression disorder

About this research paper

What this paper is about

Objective To compare the therapeutic efficacy and safety of extended release venlafaxine combined with olanzapine in treatment of major depression disorder.Methods Seventy patients were randomly assigned to therapeutic group(n=35)and control group(n=35)for 8 weeks.Therapeutic group were given extended release venlafaxine combined with olanzapine,and control group were only given extended release venlafaxine.The clinical effect was regularly assessed with HAMD.Results The therapeutic efficacy in extended release venlafaxine combined with olanzapine group was significantly higher than that in control group.Conclusions Extended release venlafaxine combined with olanzapine has better therapeutic efficacy in treatment of major depression disorder. Key words: Extended release venlafaxine; Olanzapine; Major depression disorder

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the therapeutic efficacy and safety of extended release venlafaxine combined with olanzapine in treatment of major depression disorder.Methods Seventy patients were randomly assigned to therapeutic group(n=35)and control group(n=35)for 8 weeks.Therapeutic group were given extended release venlafaxine combined with olanzapine,and control group were only given extended release venlafaxine.The clinical effect was regularly assessed with HAMD.Results The therapeutic efficacy in extended release venlafaxine combined with olanzapine group was significantly higher than that in control group.Conclusions Extended release venlafaxine combined with olanzapine has better therapeutic efficacy in treatment of major depression disorder. Key words: Extended release venlafaxine; Olanzapine; Major depression disorder

Key concepts: Olanzapine, Venlafaxine, Hamd, Venlafaxine Hydrochloride, Depression (economics), Therapeutic effect, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A controlled trial of extended release venlafaxine alone and combined with olanzapine in the treatment of major depression disorder — Research Paper | ScholarLens